Cerebrospinal fluid p62/SQSTM1 is associated with tau pathology, brain structural alterations, and cognitive impairment in adults without dementia
Liquor-p62/SQSTM1 ist mit Tau-Pathologie, strukturellen Hirnveränderungen und kognitiver Beeinträchtigung bei Erwachsenen ohne Demenz assoziiert
Journal of Alzheimer’s Disease · 30.10.2026
DOI: 10.1177/13872877261502791 ↗Auf einen Blick
Bei 557 demenzfreien Teilnehmenden war ein höherer CSF-p62/SQSTM1-Spiegel mit schlechterer Kognition, Tau-Pathologie und kleineren Hirnvolumina verbunden. Die höchste Quartile hatte ein erhöhtes Demenzrisiko.
Fragestellung
Zusammenhang von basalem CSF-p62/SQSTM1 mit Kognition, AD-Biomarkern, Hirnstruktur und inzidenter Demenz bei nicht dementen Personen.
Methode
Analyse von 557 demenzfreien Teilnehmenden der ADNI-Kohorte; multivariate Regressions-, Interaktions-, Kaplan-Meier-, Cox- und Mediationsanalysen.
Ergebnisse
Höhere CSF-p62/SQSTM1-Spiegel korrelierten mit schlechterer Kognition, erhöhter Tau-Pathologie, höheren sTREM2- und PGRN-Werten sowie kleineren Ganzhirn- und Gyrus-fusiformis-Volumina. Q4 vs. Q1: HR 1,78 (95 %-KI 1,16–2,73).
Schlussfolgerung der Autor:innen
Höhere p62/SQSTM1-Spiegel waren mit Tau-Pathologie und einem erhöhten AD-Risiko assoziiert. Tau-Pathologie und Hirnstrukturveränderungen könnten an der Beziehung zwischen p62/SQSTM1-assoziierten Autophagieprozessen und Kognition beteiligt sein.
Kernaussagen
- CSF-p62/SQSTM1 war mit schlechterer Kognition assoziiert.
- Q4 hatte ein höheres Demenzrisiko als Q1: HR 1,78.
- Tau-Pathologie und geringere Hirnvolumina vermittelten den Zusammenhang.
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, online erschienen am 30.10.2026. Verfasst von Ming-Yan Yao und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Clinical Medicine, Shandong Second Medical University, Weifang, China. Die Arbeit nennt 73 Literaturangaben. Gefördert von: the Science and Technology Innovation 2030 Major Projects, the Anhui Provincial Department of Education Scientific Research Project for Doctoral Students.
Themen: Demenz
Abstract (Originalsprache)
Background
The involvement of cerebrospinal fluid (CSF) Sequestosome-1 (SQSTM1, commonly known as p62), an autophagy-related scaffold protein, in Alzheimer's disease (AD) pathogenesis is not well established in human populations.
Objective
To investigate the associations of baseline CSF p62/SQSTM1 levels with cognitive function, AD biomarkers, brain structure, and incident dementia in non-demented individuals.
Methods
We included 557 dementia-free participants from the Alzheimer's Disease Neuroimaging Initiative cohort. Multivariate regression and interaction analyses examined associations of CSF p62/SQSTM1 with cognition, AD biomarkers, and brain volumes and their modification by age, sex, APOE genotype, and diagnostic status. Kaplan-Meier and Cox analyses assessed dementia-free survival and incident dementia risk. Mediation analysis tested whether AD pathology and brain structure mediated the association between p62/SQSTM1 and cognition.
Results
Elevated CSF p62/SQSTM1 levels correlated with poorer cognition, heightened tau pathology, increased sTREM2 and PGRN levels, and decreased whole-brain and fusiform gyrus volumes. Age modified p62/SQSTM1 associations with cognition and whole-brain volume. Subgroup analyses revealed that significant associations between p62/SQSTM1 and cognitive function (MMSE, MEM) were primarily observed in the middle-aged group. Longitudinal analyses further showed that participants in the highest quartile (Q4) exhibited an increased risk compared to the lowest (Q1) (HR = 1.78, 95% CI 1.16–2.73). Mediation analysis indicated that tau pathology and reduced brain volumes mediated the association between p62/SQSTM1 and cognition.
Conclusions
Higher p62/SQSTM1 levels were associated with tau pathology and an elevated risk of AD. Tau-related pathological changes and brain structural alterations might be involved in the relationship between the p62/SQSTM1-related autophagy processes and cognition.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Clinical Medicine, Shandong Second Medical University, Weifang, China.
- Department of Neurology, Qingdao Hospital, University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital), Qingdao, China.
- Department of Neurology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
- Department of Neurology, Qingdao Municipal Hospital, Qingdao University, Qingdao, China.
ORCID-Profile: Ming-Yan Yao, Hai-Hua Guo, Lan Tan, Hui-Fu Wang
Förderung
- the Science and Technology Innovation 2030 Major Projects
- the Anhui Provincial Department of Education Scientific Research Project for Doctoral Students
Zitieren
APA
Yao, M. Y., Guo, H. H., Li, Q. Y., Huang, L. Y., Tan, L., Wang, H. F., & Alzheimer's Disease Neuroimaging Initiative (2026). Cerebrospinal fluid p62/SQSTM1 is associated with tau pathology, brain structural alterations, and cognitive impairment in adults without dementia. Journal of Alzheimer’s Disease. https://doi.org/10.1177/13872877261502791
Vancouver
Yao MY, Guo HH, Li QY, Huang LY, Tan L, Wang HF, et al. Cerebrospinal fluid p62/SQSTM1 is associated with tau pathology, brain structural alterations, and cognitive impairment in adults without dementia. Journal of Alzheimer’s Disease. 2026. doi:10.1177/13872877261502791
BibTeX
@article{Yao2026,
author = {Yao, Ming-Yan and Guo, Hai-Hua and Li, Qiong-Yao and Huang, Liang-Yu and Tan, Lan and Wang, Hui-Fu and Alzheimer's Disease Neuroimaging Initiative, Alzheimer's Disease Neuroimaging Initiative},
title = {Cerebrospinal fluid p62/SQSTM1 is associated with tau pathology, brain structural alterations, and cognitive impairment in adults without dementia},
journal = {Journal of Alzheimer’s Disease},
year = {2026},
doi = {10.1177/13872877261502791}
}
EUVIMED